Patient Resources 10 min read·Updated 22 July 2026 Clinician-reviewed

SGLT2 Inhibitors for CKD — Patient Guide

A UK Consultant Nephrologist's patient guide to the most important new class of kidney-protecting medicines in 30 years — what dapagliflozin and empagliflozin do, who should take them, and how to stay safe.

  • Clinically Reviewed
  • NHS & NICE Aligned
  • UK Evidence-Based
  • Last Reviewed 22 July 2026

Professor Mohammed Mahdi Althaf

Consultant Nephrologist & Acute Physician

View Credentials

Professor Mohammed Mahdi Althaf

MD, MSc, PgDip (Clin Ed), FRCP, FHEA, FASN

Consultant Nephrologist & Acute Physician · GMC 7216325

View profile →

Direct answer

SGLT2 inhibitors (dapagliflozin, empagliflozin) slow CKD progression by ~40% and reduce heart failure deaths by 30%. They are now standard care for CKD with proteinuria or heart failure, with or without diabetes. Main side effect = thrush. Stop temporarily during severe illness.

Key recommendation: Slow CKD progression by ~40%.

Quick answer

✓ Best choices

  • Vegetables, lower-potassium fruit and whole grains
  • Sensible portions of fish, eggs, chicken or tofu
  • Olive oil and unsalted nuts in small amounts

✓ Foods to limit

  • Added salt and ultra-processed foods
  • Phosphate additives in processed meats and ready meals
  • Sugary and energy drinks

Key takeaway

SGLT2 inhibitors (dapagliflozin, empagliflozin) slow CKD progression by ~40% and reduce heart failure deaths by 30%. They are now standard care for CKD with proteinuria or heart failure, with or without diabetes. Main side effect = thrush. Stop temporarily during severe illness.

Who should be cautious

People on dialysis, post-transplant, pregnant or breastfeeding, or taking prescription medication — confirm with your renal team before changes.

SGLT2 Inhibitors for CKD — Patient Guide

What SGLT2 inhibitors do

SGLT2 = Sodium-Glucose Co-transporter 2 — a protein in the kidney tubule that normally reabsorbs glucose from urine back into the bloodstream.

SGLT2 inhibitors BLOCK this protein, so:

  • Glucose is lost in urine (~70 g/day = 280 kcal)
  • Sodium and water are also lost (mild diuretic effect)
  • BP falls by 3–5 mmHg
  • Weight falls by 2–3 kg over months
  • Pressure inside the kidney's filters (glomeruli) reduces — this is what protects them long-term

Benefits proven in major trials (DAPA-CKD, EMPA-KIDNEY, CREDENCE):

  • ~40% reduction in CKD progression
  • ~30% reduction in heart failure deaths
  • ~20% reduction in overall mortality
  • Effective whether you have diabetes or not
  • Effective at all CKD stages above eGFR 20

Who should take one?

NICE RECOMMENDS dapagliflozin or empagliflozin for adults with CKD if you have:

  • Type 2 diabetes (any CKD stage above eGFR 25), OR
  • Urine ACR ≥ 22.6 mg/mmol (significant proteinuria), OR
  • Heart failure with reduced or preserved ejection fraction

ALSO CONSIDERED in:

  • ADPKD (autosomal dominant polycystic kidney disease) — some evidence
  • Post-transplant — emerging evidence
  • Type 1 diabetes — specialist supervision only (DKA risk)

NOT USUALLY USED in:

  • eGFR < 20 (limited evidence; specialist decision)
  • Frequent UTIs or genital thrush
  • Active foot ulcer (canagliflozin only — slight amputation risk)
  • Pregnancy and breastfeeding

Kidney Vitality is a daily multivitamin developed by a UK Consultant Nephrologist using renal nutrition principles. It contains no added potassium, magnesium, phosphorus or iron, and no herbal blends. See the formulation.

Starting an SGLT2 inhibitor

What To Expect

  • Usual dose: dapagliflozin 10 mg once daily or empagliflozin 10 mg once daily
  • First 2 weeks: eGFR may dip by 5–10 ml/min (this is normal and protective long-term)
  • Don't be alarmed — your team expects this 'dip'
  • Drink normally — neither restrict nor over-drink
  • Continue ACE inhibitor / ARB / blood pressure meds as prescribed
  • Your renal team will check bloods at 2–4 weeks then 3 months

If You Have Diabetes

  • Insulin and sulfonylurea doses may need reducing (hypo risk)
  • Discuss with your diabetes team
  • HbA1c may fall by 5–10 mmol/mol

Side effects and how to manage them

COMMON (1 in 10):

  • Genital thrush (yeast infection) — easily treated with clotrimazole cream/pessary. Good genital hygiene helps. Continue the medication.
  • Mild dehydration — drink normally to thirst; don't restrict fluids unless told
  • Slightly more frequent urination

LESS COMMON (1 in 100):

  • UTIs — treat as normal; recurrent UTIs may mean stopping
  • Postural dizziness — especially in elderly on diuretics; sit before standing

Rare But Serious

  • Diabetic ketoacidosis (DKA) — mainly type 1 diabetes; can occur with normal blood sugars ('euglycaemic DKA'). Warning signs: nausea, vomiting, abdominal pain, fast breathing. Stop and seek urgent help.
  • Fournier's gangrene (severe genital infection) — extremely rare. Severe pain, swelling, fever — A&E immediately.
  • Lower limb amputation — only seen with canagliflozin in CANVAS trial. Avoid if active foot ulcer.

Sick-day rules — important

TEMPORARILY STOP your SGLT2 inhibitor if you have:

  • Vomiting and/or diarrhoea > 24 hours
  • Severe infection with fever and poor fluid intake
  • Surgery (stop 48 hours before; restart when eating again)
  • Acute hospital admission
  • Acute kidney injury (rising creatinine)

This prevents:

  • Dehydration
  • Euglycaemic DKA
  • Worsening AKI

RESTART when:

  • Eating and drinking normally
  • 24–48 hours after illness resolves
  • Confirmed by your GP or renal team

Also pause your ACE inhibitor / ARB and diuretics during severe illness (this is the standard 'sick-day medicines' list — your renal team will give you a card). Don't stop them long-term without advice.

Managing Diabetes with CKD
Related reading: Managing Diabetes with CKD.

Key practical tips

Designed for quick scanning — what to order, what to avoid, sensible portions, common mistakes.

  • Cook from scratch when you can
  • Read sodium labels (≤ 0.3 g per 100 g is low)
  • Take any concerns to your GP or renal team early

Clinical guidance

TL;DR summary

SGLT2 inhibitors (dapagliflozin, empagliflozin) slow CKD progression by ~40% and reduce heart failure deaths by 30%. They are now standard care for CKD with proteinuria or heart failure, with or without diabetes. Main side effect = thrush. Stop temporarily during severe illness.

Key takeaways
  • Slow CKD progression by ~40%.
  • Licensed for CKD with or without diabetes.
  • Continue down to eGFR ~20–25.
  • Sick-day rules: pause if severely unwell.
  • Most common side effect = thrush, easily treated.
Kidney Diet & Nutrition Considerations

Diet is one of the most powerful tools you have to look after your kidneys. UK renal guidance points to a Mediterranean-style, reduced-salt pattern: plenty of vegetables, lower-potassium fruit, whole grains, sensible protein, beans and pulses in moderation, oily fish and olive oil. Personal targets — for potassium, phosphate, protein and fluid — should be set by your renal team based on your bloods.

Foods to prioritise

  • Vegetables, lower-potassium fruit and whole grains
  • Sensible portions of fish, eggs, chicken or tofu
  • Olive oil and unsalted nuts in small amounts

Foods to limit

  • Added salt and ultra-processed foods
  • Phosphate additives in processed meats and ready meals
  • Sugary and energy drinks

Potassium, phosphate and protein needs vary between individuals — please confirm personal targets with your renal team or dietitian. Browse the Kidney Diet Hub for more guides in this cluster.

Frequently asked questions

What are SGLT2 inhibitors?

SGLT2 inhibitors (dapagliflozin/Forxiga, empagliflozin/Jardiance, canagliflozin/Invokana) are tablets that make the kidneys excrete extra glucose and sodium in urine. They were developed for diabetes but turned out to be powerful kidney and heart protectors — even in people without diabetes.

Do I need diabetes to take an SGLT2 inhibitor?

No. Since 2021, dapagliflozin and empagliflozin are licensed and NICE-approved for CKD with or without diabetes, provided you have proteinuria (urine ACR ≥ 22.6) or heart failure. They slow CKD progression by ~40%.

What are the side effects?

Most common: genital thrush (yeast infection) — easily treated with clotrimazole. Less common: UTIs, dehydration if you reduce fluids too much. Rare but important: diabetic ketoacidosis (DKA) — usually only in type 1 diabetes or during severe illness.

What are 'sick day rules' for SGLT2 inhibitors?

STOP your SGLT2 inhibitor temporarily if you have: severe vomiting/diarrhoea, can't eat normally for > 24 hours, fever with poor fluid intake, before major surgery (48h before), or if hospitalised acutely. Restart when you're eating and drinking normally again.

What foods are good for kidney health?

A Mediterranean-style, mostly plant-based, reduced-salt diet is the most consistent evidence-based pattern for kidney health. Build meals around vegetables, lower-potassium fruit, whole grains, fish, eggs or tofu, beans and pulses in moderation, and olive oil.

Nutritional challenges in kidney disease

Many people living with kidney disease have to limit foods because of potassium, phosphate, diabetes, dialysis, appetite changes or simply the time it takes to cook from scratch every day. That can make it harder to keep daily nutrition balanced — particularly for vitamins and minerals that food alone may not fully cover.

Kidney Vitality is a UK-formulated daily nutritional support product designed by Consultant Nephrologist Professor Mohammed Mahdi Althaf with renal nutrition in mind from the start. It keeps doses moderate, leaves out added potassium, phosphate and magnesium, and avoids megadose vitamin A — sitting alongside a kidney-friendly diet, not replacing it.

Why Kidney Vitality fits this need

Built around UK renal guidance

Aligned with NICE TA775 (dapagliflozin for CKD), NICE TA942 (empagliflozin), and KDIGO 2024 CKD guidance.

Designed by a UK Consultant Nephrologist

Formulated and reviewed by Professor Mohammed Mahdi Althaf (GMC 7216325).

Evidence-based by design

Practical UK patient guidance on the most important new CKD drug class.

Designed by a UK Consultant Nephrologist

Ready to support your kidney health?

If you have been researching kidney health, supplements, CKD nutrition or kidney-friendly living, Kidney Vitality was developed specifically around those principles by Professor Mohammed Mahdi Althaf (GMC 7216325). Nephrologist Developed Daily Multivitamin.

  • No Added Potassium
  • No Added Magnesium
  • No Added Phosphorus
  • No Added Iron
  • One capsule daily
  • UK GMP — BRCGS, NSF GMP, Halal

✓ Free UK tracked delivery  ·  ✓ Delivered every 30 days  ·  ✓ Pause or cancel anytime  ·  ✓ Never run out

ComparisonKidney VitalityTypical high-street multivitamin
Added potassiumNoneOften included
Added phosphateNoneOften included (E338–E452)
Vitamin A (retinol)No megadoseOften high-dose retinol
Kidney-focused formulationYesNo — general population
Consultant Nephrologist involvementYes (GMC 7216325)No
UK GMP manufacturedYes (BRCGS, NSF GMP)Varies

Food supplement. Not a medicine and not a treatment for kidney disease. Speak with your GP, pharmacist or renal team before starting any new supplement, especially in advanced CKD, on dialysis, post-transplant, pregnant or breastfeeding.

Clinical reviewer

Professor Mohammed Mahdi Althaf

Consultant Nephrologist

Acute Physician

GMC 7216325

View Full Biography

Professor Mohammed Mahdi Althaf is a UK Consultant Nephrologist and Acute Physician with a special interest in chronic kidney disease, AKI prevention and renal nutrition. He combines hospital practice with patient education and clinical guidance review.

View professional profile →
View Credentials
  • MD
  • MSc
  • PgDip (Clin Ed)
  • FRCP
  • FHEA
  • FASN

About this article

Written for UK patients and based on:

  • NICE guidance
  • NHS resources
  • British Dietetic Association guidance
  • Kidney Care UK resources
View methodology

Each article is researched against current UK clinical guidance (NICE NG203, NG118, NG136), NHS patient resources, KDIGO and KDOQI international guidelines, and the British Dietetic Association Renal Nutrition Group. Drafts are written by the Kidney Vitality editorial team and reviewed by a UK Consultant Nephrologist before publication. Content is reviewed on a rolling basis and updated when guidance changes.

Editorial standards

  • Clinically reviewed
  • NHS-aligned
  • NICE-aligned
  • Evidence-based
  • Reviewed before publication
View full editorial process

Every article is researched and written by the Kidney Vitality editorial team using current UK clinical guidance (NICE NG203, NG118, NG136), NHS patient resources, KDIGO/KDOQI international guidelines, and British Dietetic Association renal nutrition guidance. Drafts are reviewed for clinical accuracy by Professor Mohammed Mahdi Althaf, MD, MSc, PgDip (Clin Ed), FRCP, FHEA, FASN (Consultant Nephrologist & Acute Physician, GMC 7216325) before publication. Content is updated when UK guidance changes.

References (4)View Sources
  1. NICE NG203: Chronic kidney disease — assessment and management
  2. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD
  3. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update
  4. British Dietetic Association — Renal Nutrition Group

Medical disclaimer

This content is educational only and does not replace personalised medical advice.

Read full disclaimer

This page is general information, not personal medical advice. If you have chronic kidney disease, are on dialysis, have had a kidney transplant, are pregnant or breastfeeding, or take prescription medication, please confirm any supplement with your GP, pharmacist or renal team before starting.